Clinical trial
A Pilot Study: Metformin as an Inflammatory Modulating Therapy in Older Adults Without Diabetes
NCT03772964 is registered in ClinicalTrials.gov with Brian Zuckerbraun as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study: Metformin as an Inflammatory Modulating Therapy in Older Adults Without Diabetes
- Lead sponsor
- Brian Zuckerbraun
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 22, 2019
- Completion date
- March 31, 2020
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory response